Aravive
-$0.25 (-4.59%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours
Why Robinhood?
You can buy or sell Aravive and other stocks, options, and ETFs commission-free!
About ARAV
Aravive, Inc. operates as a clinical stage biotechnology company. The firm engages in the development of new therapies that target important survival pathways for both advanced solid tumors as well as hematologic malignancies.
CEO
Gail Frances McIntyre
Employees
17
Headquarters
Houston, Texas
Founded
2008
Market Cap
102.43M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
165.53K
High Today
$5.56
Low Today
$5.16
Open Price
$5.42
Volume
149.53K
52 Week High
$14.94
52 Week Low
$4.27
ARAV Earnings
-$0.72
-$0.48
-$0.24
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 26, Pre-Market